Monday, Dec 18, 2017
engineered enzymes for better healthcare

NeoScreenPak is a single-format test package which will be used to screen for seven of the eleven most commonly screened disorders affecting newborns.

PKU Phenylketonuria Product Info
MSUD          Maple Syrup Urine Disease Product Info
HCY Homocystinuria Product Info
TYR-I Tyrosinaemia Type-I Product Info
GAL Galactosaemia Product Info
G6PD Glucose-6P Dehydrogenase Deficiency                   Product Info
BIO Biotinidase Deficiency Product Info

Enzolve’s ‘one-step’ tests are faster and more reliable, convenient and cost effective than tests currently available on the market.


Technology                                Advantages                                     Pipeline

Language Selection

Search

Latest News

Newborn Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…

Read more...

Screen your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…

Read more...

UCD campus company to begin production of newborn screening kits for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…

Read more...